This test is not orderable.

OnkoSight NGS MDS Panel Build info

Synonyms

  • ONKOSIGHT NGS MDS PANEL
  • MYELODYSPLASTIC SYNDROME
  • LAB4140

Short Name

ONKOSIGHT NGS MDS PANEL

Procedure Master Number

LAB4140

Procedure ID

189679

Clinical Info

Tumor sequencing by NGS detecting mutations in 18 genes associated with MDS. Mutations often have prognostic significance, may confer resistance 
to FDA approved therapies, or may qualify patients for late-stage clinical trials.

Specimen Sources

 Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

 Blood

Container

Lavender Top Tube

Collection Instructions

Container/Tube: Lavender top tube
Specimen: 2 mL Bone Marrow or Whole Blood
Alternate Specimens: Bone Marrow - Green Top, Peripheral Blood - Lavender Top,
Peripheral Blood - Green Top, Eppendorf tube, Unstained Slide, Formalin-fixed,
Paraffin-embedded tissue 
Decalcified specimens are not recommended for NGS testing
Note: Please indicate specimen type

Transport Instructions

Room Temperature

Specimen Stability

30 Days Room Temperature

Methodology

Genotyping by Next Generation Sequencing
Genes:
ASXL1; BCOR; CBL;DNMT3A; ETV6; EZH2
JAK2; KRAS; NRAS; PTPN11; RUNX1; SETBP1
SF3B1; SRSF2; TET2; TP53; U2AF1; ZRSR2

Days Performed

TAT 10 - 12 Days

Performing Laboratory

GenPath BioReference
Test Code: TL98

CPT

81450

PDM

 1659926

Only Orderable at Locations:

 Orderable Everywhere

Results
Component Name Base Name Common Name External Name
ONKOSIGHT ADVANCED NGS MDS PANEL ONKONGSMDS ONKOSIGHT ADVANCED NGS MDS PANEL
THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS THERPROGASS THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS Therapeutic And Prognostic Associations
INTERPRETATION SUMMARY INTERP INTERPRETATION SUMMARY Interpretation Summary
DETAILED GENETIC INTERPRETATION 1 DETAILGENINT DETAILED GENETIC INTERPRETATION 1 Detailed Genetic Interpretation 1
DETAILED GENETIC INTERPRETATION 2 : DETAILGENINT DETAILED GENETIC INTERPRETATION 2 Detailed Genetic Interpretation 2 :
CLINICAL TRIALS 1 : CLINTRIAL CLINICAL TRIALS 1 Clinical Trials 1 :
CLINICAL TRIALS 2 : CLINTRIAL CLINICAL TRIALS 2 Clinical Trials 2 :
TECHNICAL SUMMARY : TECHSUM TECHNICAL SUMMARY Technical Summary :
METHODS METHODS METHODS Methods
REFERENCES 1 REF1 REFERENCES 1 References 1
REFERENCES 2 REF2 REFERENCES 2 References 2
REPORT FOOTER RPTFOOTER REPORT FOOTER Report Footer
ADDENDUM : ADDENDUM ADDENDUM
ALLELE FREQUENCIES: ALLELE ALLELE FREQUENCIES Allele Frequencies: